Shire

News

Takeda hurries $62bn Shire acquisition, calls investor vote ...

Takeda will hold an investor vote on its $62 billion acquisition of Shire next month, and aims to close the deal on January 8.

News

Takeda CEO confident about Shire merger

Takeda’s CEO has said he is confident that its $62 billion acquisition of Shire will go ahead, despite a rebellion from a dissident group of shareholders.

News

Takeda proposes selling Shire’s IBD treatment after merger

Takeda has proposed selling off a Shire treatment for inflammatory bowel disease when the companies merge next year, to avoid an overlap with its own drug.

News

Bruce T. Martin Photography
508-655-7557
btm@brucetmartin.com
154 East Central St
Natick MA 01760

FDA advisers back Shire constipation drug

Shire’s constipation drug prucalopride is moving closer to market – advisers to the FDA have just unanimously backed it as a treatment for chronic idiopathic constipation (CIC) in adults.

News

FDA rejects Pharming's Ruconest HAE label expansion

The FDA has rejected Pharming’s application to expand the licence of Ruconest, for a use as prophylaxis for patients with the serious rare disease hereditary angioedema (HAE).

News